Sarepta Therapeutics (SRPT) Times Interest Earned (2010 - 2026)
Sarepta Therapeutics' (SRPT) quarterly Times Interest Earned came in at $0.35 in Q1 2026, up 214.12% year-on-year from $0.11 in Q1 2025, and down 96.63% quarter-over-quarter from $10.28 in Q4 2025.
Sarepta Therapeutics (SRPT) Times Interest Earned (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Times Interest Earned history runs 17 years deep, the most recent figure standing at $0.35 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 214.12% year-over-year to $0.35 in Q1 2026; TTM through Mar 2026 was -$0.04, a 66.58% increase from a year earlier, with the FY2025 full-year figure at -$0.63, down 223.21% from the prior year.
- Times Interest Earned slipped to $0.35 in Q1 2026 per SRPT's latest filing, from $10.28 in the prior quarter.
- Across five years, Times Interest Earned topped out at $10.28 in Q4 2025 and bottomed at -$25.56 in Q2 2023.
- The 5-year median for Times Interest Earned is -$0.15 (2024), against an average of -$3.07.
- Across the five-year window, Times Interest Earned jumped 1418.86% in 2024 and plunged 479.67% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $1.13 in 2022, then plunged by 156.17% to -$0.63 in 2023, then soared by 1418.86% to $8.37 in 2024, then grew by 22.76% to $10.28 in 2025, then sank by 96.63% to $0.35 in 2026.
- Per Business Quant, the three latest SRPT Times Interest Earned figures stand at $0.35 (Q1 2026), $10.28 (Q4 2025), and -$0.09 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 10.28 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | 0.10 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | 8.37 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | 4.86 |
| Dec 31, 2023 | -0.63 |
| Sep 30, 2023 | -3.99 |
| Jun 30, 2023 | -25.56 |
| Mar 31, 2023 | -19.66 |
| Dec 31, 2022 | 1.13 |
| Sep 30, 2022 | -8.91 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -5.50 |
| Dec 31, 2021 | -9.48 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | -10.35 |